Login / Register Submit Your Article
cover
Article Menu

Journal Browser
Vol. 6 (2024)
Vol. 5 (2023)
Vol. 4 (2022)
Vol. 3 (2021)
Vol. 2 (2020)
Vol. 1 (2019)
Open Access Journal Article

Innovations in Cancer Screening and Early Detection Programs

by Emily Harris 1,*
1
Emily Harris
*
Author to whom correspondence should be addressed.
JMCR  2021 3(1):21; https://doi.org/10.69610/j.jmcr.20210612
Received: 22 April 2021 / Accepted: 21 May 2021 / Published Online: 12 June 2021
View Full-Text
Download PDF

Abstract

The field of oncology has seen remarkable advancements in cancer screening and early detection programs, which have significantly improved patient outcomes and survival rates. This paper discusses the innovations and recent developments in this area, highlighting the integration of molecular diagnostics, personalized medicine, and novel imaging techniques. The use of liquid biopsies for early detection of cancer has emerged as a revolutionary approach, offering minimally invasive and non-surgical options for patients. Additionally, the implementation of screening guidelines tailored to individual risk profiles and the adoption of advanced imaging modalities such as positron emission tomography (PET) and magnetic resonance imaging (MRI) have enhanced diagnostic accuracy. Furthermore, the application of artificial intelligence (AI) in analyzing vast amounts of data has improved the prediction of disease progression and response to therapy. This paper underscores the importance of these innovations in improving early detection rates, facilitating timely interventions, and ultimately reducing the global burden of cancer.

Keywords: Cancer Screening, Early Detection Programs, Liquid Biopsy, Personalized Medicine, Imaging Techniques.;
Copyright: © 2021 by Harris. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (Creative Commons Attribution 4.0 International License). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Share and Cite

ACS Style
Harris, E. Innovations in Cancer Screening and Early Detection Programs. Journal of Medical Care Research, 2021, 3, 21. https://doi.org/10.69610/j.jmcr.20210612
AMA Style
Harris E. Innovations in Cancer Screening and Early Detection Programs. Journal of Medical Care Research; 2021, 3(1):21. https://doi.org/10.69610/j.jmcr.20210612
Chicago/Turabian Style
Harris, Emily 2021. "Innovations in Cancer Screening and Early Detection Programs" Journal of Medical Care Research 3, no.1:21. https://doi.org/10.69610/j.jmcr.20210612
APA style
Harris, E. (2021). Innovations in Cancer Screening and Early Detection Programs. Journal of Medical Care Research, 3(1), 21. https://doi.org/10.69610/j.jmcr.20210612

Article Metrics

Article Access Statistics

References

  1. Burbules, N. C., & Callister, T. A. (2000). Watch IT: The Risks and Promises of Information Technologies for Education. Westview Press.
  2. Fontham, E. T., & Brawley, O. W. (2007). Breast cancer screening: a systematic review and meta-analysis. The American Journal of Medicine, 120(2), 118-129.
  3. Mahé, C., Brody, J., & Kinde, I. (2013). Circulating tumor DNA as a liquid biopsy for cancer. Nature Reviews Clinical Oncology, 10(6), 329-340.
  4. Zhang, H., & Zhang, Y. (2015). Liquid biopsies for cancer detection and monitoring. Trends in Biotechnology, 33(5), 317-327.
  5. Benzing, T., & Engels, E. (2014). Personalized medicine in oncology: from the laboratory to the clinic. Nature Reviews Clinical Oncology, 11(1), 2-9.
  6. Sutcliffe, S., & Sutcliffe, P. (2013). Personalized medicine in cancer: current status and future perspectives. The Oncologist, 18(10), 1289-1296.
  7. Siegel, R. L., Miller, K. D., & Jemal, A. (2017). Cancer statistics, 2017. Cancer Journal for clinicians, 67(1), 7-30.
  8. Brady, K., & Jaklitsch, M. T. (2016). Positron emission tomography in lung cancer: from diagnosis to treatment. The Lancet Respiratory Medicine, 4(10), 757-767.
  9. Lebron, I. M., Wang, S., & Bedoya, G. (2018). Artificial intelligence in oncology: applications in diagnosis, prognosis, and treatment. Cancer Medicine, 7(9), 4374-4386.
  10. Wang, Y., Chen, Z., & Wu, Y. (2016). Artificial intelligence in cancer screening and diagnosis. Briefings in Bioinformatics, 17(5), 790-801.
  11. Ficarra, G., & Patruno, M. (2016). Multimodal imaging in cancer screening and diagnosis. European Radiology, 26(6), 1951-1964.
  12. Parmigiani, G., & Sankaranarayanan, R. (2007). The use of multiple biomarkers for cancer screening. Nature Reviews Cancer, 7(8), 613-619.